Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension.
D000328:Adult; D001545:Benserazide / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004347:Drug Interactions; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology*; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008750:Methyldopa / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D008875:Middle Aged; D010919:Placebos
D006834:Hydrazines; D010919:Placebos; D008750:Methyldopa; D001545:Benserazide